Skip to content
MENU
SELECTED
PUBLICATIONS
2022
Phagocytosing differentiated cell-fragments is a novel mechanism for controlling somatic stem cell differentiation within a short time frame
LEARN MORE
2021
Multilineage-differentiating stress-enduring cells alleviate atopic dermatitis-associated behaviors in mice
LEARN MORE
2021
Muse Cells Have Higher Stress Tolerance than Adipose Stem Cells due to the Overexpression of the CCNA2 Gene
LEARN MORE
2021
Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy
LEARN MORE
2021
Protection of liver sinusoids by intravenous administration of human Muse cells in a rat extra-small partial liver transplantation model
LEARN MORE
2021
Why Do Muse Stem Cells Present an Enduring Stress Capacity? Hints from a Comparative Proteome Analysis
LEARN MORE
Page
1
Page
2
Page
3
Page
4
Page
5
Clinical Trials & Clinical Data
2024
Accumulation of endogenous Muse cells in the myocardium and its pathophysiological role in patients with fulminant myocarditis
LEARN MORE
2024
Safety and tolerability of a Muse cell-based product in neonatal hypoxic-ischemic encephalopathy with therapeutic hypothermia (SHIELD trial)
LEARN MORE
2024
Safety and feasibility of intravenous administration of a single dose of allogenic-Muse cells to treat human cervical traumatic spinal cord injury: a clinical trial
LEARN MORE
2024
Donor Muse Cell Treatment Without HLA-Matching Tests and Immunosuppressant Treatmen
LEARN MORE
2023
Safety and Clinical Effects of a Muse Cell-Based Product in Patients With Amyotrophic Lateral Sclerosis: Results of a Phase 2 Clinical Trial
LEARN MORE
2023
Randomized placebo-controlled trial of CL2020, an allogenic muse cell-based product, in subacute ischemic stroke
LEARN MORE
Page
1
Page
2
Page
3
NEWS
2024
Muse Cells: A New Stem Cell Treatment
LEARN MORE
Home
Our Science
About
Publications
Contact
Home
Our Science
About
Publications
Contact
